An Open-Label, Randomized, 2-Cohort, Single-Dose, Crossover Study To Estimate The Effects Of Food On Oxycodone Pharmacokinetics Following Oral Administration Of 40 Mg Doses Of Pf 00345439 Formulation K Taken Whole Or After Chewing In Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 06 Apr 2016
At a glance
- Drugs Oxycodone (Primary)
- Indications Pain
- Focus Pharmacokinetics
- Sponsors Pfizer
- 15 Aug 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 29 Jul 2014 Planned End Date changed from 1 Jun 2014 to 1 Jul 2014 as reported by ClinicalTrials.gov.
- 29 Jul 2014 Planned primary completion date changed from 1 Jun 2014 to 1 Jul 2014 as reported by ClinicalTrials.gov.